Channel Partner CTC Life Sciences Corporation Expands Sales and Support Teams to Meet Industry Demand for QUMAS Solutions

Channel Partner CTC Life Sciences Corporation Expands Sales and Support Teams to Meet Industry Demand for QUMAS Solutions

 

To view this PR in Japanese, click here

Cork, Ireland – July 2, 2014QUMAS, today announced that CTC Life Sciences Corporation (CTCLS), a leading solution provider based in Japan, has expanded its sales and support staffs that focus on QUMAS solutions. CTC Life Sciences Corporation is authorized to sell and support the following QUMAS solutions throughout Japan:

  • QUMAS DocCompliance, a best-in-class electronic document and content management system.
  • QUMAS ProcessCompliance, a leading Enterprise Quality Management Solution (EQMS) that can be configured to manage a wide range a wide range of compliance, quality and operational activities, including CAPAs, Deviations, Complaints and Audits.
  • QUMAS ComplianceSP, an easy-to-use, collaborative platform based on SharePoint 2010 that delivers a comprehensive set of capabilities around document and quality management processes.
  • QUMAS iX, a cloud-based solution that creates a bridge between an organization’s internal document management system and a qualified environment for exchanging controlled regulatory and GxP information with third parties that is safe, secure and scalable.

CTC Life Sciences has played a key role in securing a reference base of customers in Japan. A number of customers in Japan have already deployed QUMAS solutions for use in Clinical, Regulatory, CMC, Quality and Manufacturing. Additionally, CTCLS has completed successful on-premise and in the cloud QUMAS implementations based on SharePoint, SQL Server and Oracle platforms.

“The market dictated that we increase our staff that sells and supports QUMAS solutions,” stated Ryouji Yokoyama, President and CEO for CTC Life Sciences Corporation. “Our base of QUMAS customers is growing and we are seeing strong demand from Life Sciences companies based in Japan for compliance and quality management solutions. All of the solutions available from QUMAS are configurable. That resonates with our target market because they know that can purchase a best-in-class solution that can be easily modified when regulatory requirements change.”

“CTC Life Sciences Corporation has been a valued partner of ours for a number of years now and we’re delighted with this announcement,” said Kevin O’Leary, CEO QUMAS. “We are looking forward to working with the new team members at CTCLS.”

About CTC Life Sciences Corporation (CTCLS)

CTC Life Sciences Corporation was established in 1989 and currently has over 200 employees. On April 1, 2014, in accordance with changing the company name to CTC Life Science Corporation, CTCLS established a new business strategy that expands their operations from the research area of life sciences into additional areas of life sciences including manufacturing, clinical, and healthcare.

CTCLS will continue to provide customers better solutions, with high-quality consulting capabilities backed by knowledge of and experience in the pharmaceutical industry, and also the all-round system building skill in cooperation with its corporate parent, ITOCHU Techno-Science Corporation (abbreviated as “CTC”) and its group companies.

For more information visit http://www.ctcls.co.jp/index.html.

About QUMAS

QUMAS, a product portfolio in the brand BIOVIA from Dassault Systèmes, is the leader in Regulatory, Quality, and Compliance Management Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Gold Microsoft Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, EMC Documentum, Oracle or SQL. For more information, visit www.qumas.com.

About BIOVIA

BIOVIA is a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. BIOVIA provides a broad, flexible scientific foundation optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, QA/QC and manufacturing phases of product development. BIOVIA offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using BIOVIA’s technology, scientific innovators can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing.

BIOVIA solutions are used by more than 2,000 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., BIOVIA employs approximately 225 full-time PhD scientists. For more information about BIOVIA, visit www.accelrys.com.

UPDATE: On January 30, 2014, Dassault Systèmes, the 3DEXPERIENCE Company and Accelrys, Inc. announced the signing of a definitive merger agreement for Dassault Systèmes to acquire Accelrys. Under the terms and conditions of the merger agreement, Dassault Systèmes made an all-cash tender offer for all of the outstanding shares of Accelrys common stock. The tender offer statement and other documents filed by Dassault Systèmes and Accelrys with the SEC are available for free at the SEC’s website (http://www.sec.gov) and may be obtained at no charge by directing a request by mail to Innisfree M&A Incorporated, 501 Madison Avenue, 20th Floor, New York, New York, 10022 or by calling (888) 750-5834.

The tender offer process was completed on April 29, 2014. Accelrys filed Form 15 (Certification and Notice of Termination of Registration) with the SEC on May 9, meaning Accelrys is no longer publicly traded (and the company’s NASDAQ listing will shortly expire).

Combining with Accelrys will enrich the molecular chemistry capabilities from discovery to manufacturing and regulatory requirements of Dassault Systèmes’ formulation-based industry offerings such as life sciences, consumer packaged goods, high tech and energy, as well as advanced manufacturing industries.

Accelrys is now BIOVIA a brand of Dassault Systèmes.

 

All trade names, trademarks, and service marks are rightful property of their respective owners.